{"nct_id":"NCT03104413","title":"A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2017-12-18","start_date_type":"ACTUAL","primary_completion_date":"2020-11-30","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}